What You Should Know:
- SimonMed Imaging, a provider of outpatient medical imaging services in the United States, today announced the nationwide launch of its AI-enabled Personalized Breast Cancer Detection (PBCD) program.
- The program offers women a more comprehensive and personalized approach to breast cancer screening, empowering them to make informed decisions about their health.
PBCD Program Costs
For a cost of $40, patients can add the PBCD program to their
Read More
Breast Cancer
ScreenPoint Medical Acquires Biomediq to Enhance Breast Cancer Risk Assessment with AI
What You Should Know:
- ScreenPoint Medical, a provider of AI-powered breast cancer screening solutions, acquires Biomediq A/S, a research-based company specializing in quantitative imaging biomarkers. Financial details of the acquisition were not disclosed.
- ScreenPoint's industry-leading Transpara AI platform will now incorporate Biomediq's advanced risk analysis technology, which enables automated analysis of 2D and 3D mammograms to assess future breast cancer risk. This
Read More
GE HealthCare Unveils Mammography System to Improve Patient-Centered Breast Care
What You Should Know:
- GE HealthCare has announced the launch of its new Pristina Via™ mammography system, designed to improve the screening experience for both technologists and patients. This innovative system, debuting at the Radiological Society of North America's 2024 Annual Meeting, addresses the growing need for efficient workflows and personalized care in breast imaging.
- GE HealthCare developed Pristina Via™ based on extensive feedback from mammography technologists. The company
Read More
Lunit Partners with VIDI Group to Deliver AI-Powered Mammography to France’s Largest Radiology Network
What You Should Know:
- Lunit, a leading provider of AI-powered cancer diagnostics solutions, has announced a strategic alliance with VIDI Group, the largest private radiology and radiotherapy network in France.
- The partnership will expand the deployment of Lunit INSIGHT MMG, an AI solution for breast cancer screening, across VIDI's extensive network of over 400 sites and 1,200 doctors.
Improving Breast Cancer Detection
Lunit INSIGHT MMG is designed to assist
Read More
Baptist Health South Florida to Deploy MICA AI’s AI-Powered Mammograms
What You Should Know:
- MICA Artificial Intelligence and Baptist Health South Florida have joined forces in a groundbreaking collaboration to transform breast cancer detection.
- By integrating MICA AI's innovative technology into mammography, the collaboration aims to improve the accuracy and efficiency of breast cancer screening, leading to earlier diagnosis and better patient outcomes.
AI-Powered Mammogram Insights for Earlier Breast Cancer Detection
MICA AI, developed
Read More
Volpara Health Secures $7.3M Contract to Modernize Breast Cancer Screening for U.S. Military
What You Should Know:
- Volpara Health, a global leader in cancer detection software, has been awarded a significant contract with the U.S. Defense Health Agency (DHA) valued at $7.3M over five years.
- The contract will deploy Volpara's Patient Hub™ across the DHA's military health system, modernizing breast cancer screening and patient management for active-duty military personnel, retirees, and their families.
Enhancing Breast Health Management for Military
Read More
Vara Raises $8.9M to Expand AI-Powered Breast Cancer Screening Globally
What You Should Know:
- Vara, a Berlin, Germany-based provider of AI-enabled breast cancer detection, has announced the successful closure of a $8.9M (€8M EUR) Series B funding round.
- This investment, co-led by Smart Family Office, FJH, and IBB Ventures, will fuel Vara's continued expansion and its mission to revolutionize breast cancer screening through artificial intelligence.
Transforming Breast Cancer Screening with AI
Vara's AI-powered software has been shown to
Read More
LG Launches 5MP Diagnostic Monitor for Breast Imaging
What You Should Know:
- LG Electronics launches its latest addition to its diagnostic monitor lineup, the 21HQ613D-B. This 21.3-inch 5-megapixel (MP) IPS monitor has received FDA clearance for digital mammography and breast tomosynthesis.
- The new 5MP monitor is designed to improve workflow efficiency by providing healthcare professionals with the tools they need to accurately and comfortably review medical images.
Enhanced Image Quality and User Experience
The
Read More
Mika Health, AstraZeneca, and Daiichi Sankyo Partner on UNITE Program
What You Should Know:
- Mika Health, a leading developer of digital therapeutics for cancer patients, announced a collaborative initiative called "UNITE" alongside pharmaceutical giants AstraZeneca and Daiichi Sankyo.
- The strategic initiative signifies a commitment to cross-industry collaboration to enhance the lives of cancer patients and is expected to pave the way for AI-powered solutions in other disease areas.
Mika Health: A Proven Digital Therapeutic Platform
Mika
Read More
New AI Test Aims to Improve Breast Cancer Recurrence Prediction: COTA, PreciseDx, and Baptist Health South Florida Collaborate
What You Should Know:
- A collaborative effort between COTA, PreciseDx, and Baptist Health South Florida seeks to revolutionize breast cancer recurrence risk assessment with the PreciseBreast™ (PDxBr) test. This AI-powered tool holds promise for faster, more accurate, and more affordable risk prediction compared to current methods.
- By utilizing AI technology, PreciseBreast™ has the potential to offer patients a faster, more accurate, and more affordable way to assess their risk of
Read More
